8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.40%
Revenue growth under 50% of 3141.T's 5.15%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.40%
Gross profit growth above 1.5x 3141.T's 0.08%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-2.91%
Negative EBIT growth while 3141.T is at 20.98%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
4.04%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
-15.54%
Negative net income growth while 3141.T stands at 26.18%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.54%
Negative EPS growth while 3141.T is at 26.22%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.54%
Negative diluted EPS growth while 3141.T is at 26.08%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share reduction more than 1.5x 3141.T's 0.05%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.00%
Diluted share reduction more than 1.5x 3141.T's 0.09%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.57%
10Y revenue/share CAGR under 50% of 3141.T's 133.18%. Michael Burry would suspect a lasting competitive disadvantage.
57.04%
5Y revenue/share CAGR at 50-75% of 3141.T's 84.70%. Martin Whitman would worry about a lagging mid-term growth trajectory.
29.96%
3Y revenue/share CAGR at 75-90% of 3141.T's 36.55%. Bill Ackman would expect new product strategies to close the gap.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
86.45%
Below 50% of 3141.T's 397.69%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
86.04%
5Y net income/share CAGR at 50-75% of 3141.T's 165.72%. Martin Whitman might see a shortfall in operational efficiency or brand power.
9.43%
Below 50% of 3141.T's 93.37%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
130.07%
5Y equity/share CAGR above 1.5x 3141.T's 79.64%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
62.57%
3Y equity/share CAGR above 1.5x 3141.T's 38.49%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-100.00%
Cut dividends over 10 years while 3141.T stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-39.20%
Firm’s AR is declining while 3141.T shows 13.99%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-3.35%
Inventory is declining while 3141.T stands at 6.79%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.06%
Asset growth well under 50% of 3141.T's 4.19%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.14%
1.25-1.5x 3141.T's 2.26%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-41.08%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
96.39%
SG&A growth well above 3141.T's 38.81%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.